Patient 1 – acute abdomen 19 year old male – no prior medical history Just back from a trip to Israel Two days of “writhing in pain”, fever to 102.5 –

Slides:



Advertisements
Similar presentations
Immunomodulators and Biologics Maria T. Abreu, MD University of Miami Miller School of Medicine Miami, Florida.
Advertisements

”FIRST AND FINEST” Lupus Enteritis: A Pain in the Gut LT James Prim, DO LCDR Shauna O’Sullivan, DO Naval Medical Center Portsmouth.
Lower Gastrointestinal Bleeding
Colitis in the Very Young
Management of Inflammatory bowel disease 8/12/10.
NYU Medical Grand Rounds Clinical Vignette Rennie Rhee MD, PGY-2 January 13, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
HPI A 25 year old Caucasian male presents to your clinic with two month history of crampy abdominal pain and diarrhea. What else would you like to know?
Advances in Inflammatory Bowel Diseases 2014 Millie Boettcher, MSN, PPCNP Children’s Hospital of Philadelphia Division of Gastroenterology, Hepatology.
Thiopurines still have a role in the management of pediatric IBD Athos Bousvaros MD, MPH Associate Director, IBD program Boston Children’s Hospital.
How do we manage perforated Crohn’s Disease? Daniel von Allmen, MD Cincinnati Children’s Hospital Medical Center Cincinnati, Ohio.
Ulcerative Colitis.
The Patient With Pyoderma Gangrenosum Maria T. Abreu, MD Chief, Division of Gastroenterology University of Miami Miller School of Medicine Miami, Florida.
Ghassan Wahbeh MD Associate Professor, Director IBD Program Seattle Children’s Hospital University of Washington.
Management of Clostridium difficile Infections
Progress in Diagnosing and Treating Clostridium difficile in IBD patients Alan C. Moss MD, FEBG, FACG, AGAF Associate Professor of Medicine Director of.
Inflammatory Bowel Disease
Inflammatory Bowel Disease
Pediatric IBD Research
UC. Ulcerative Colitis ( UC ) Ulcerative colitis is an inflammatory bowel disease (IBD) that causes chronic inflammation of the digestive tract It is.
Inflammatory Bowel Disease Treatment. Epidemiology Clinical Laboratory Imaging Pathology Response to treatment IBD.
Inflammatory Bowel Diseases Dr. Nematollah Ahangar Assistant Prof. of Pharmacology.
Crohn’s Disease Presenting as Intestinal Parasites “I got worms…” Poster by Jared Halterman, Kade Rasmussen DO, and Joseph Dougherty DO A 14 year-old male.
Is the capsule a guiding star ? Dr. Niv Eva Department of Gastroenterology Tel-Aviv Sourasky Medical Center.
What are we talking about? Functional gastrointestinal disorders (FGIDs) are defined as a variable combination of chronic or recurrent gastrointestinal.
By: Leon Richardson Period 2
Raneen Omary. Contents Definition Pathogenesis Epidemiology Acute Radiation Enteritis Chronic Radiation Enteritis Risk Factors Diagnosis DD Medical Management.
CASE HISTORY #1 AIBD Breakout Session Douglas C. Wolf, M.D.
NYU Medical Grand Rounds Clinical Vignette Verity Schaye MD, PGY-2 February 3, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Malignancy  NHL 7.7% - mostly extranodal, all B cell type  Others - –Waldenstrom’s macroglobulinemia –Hodgkin’s disease –Adenocarcinoma - stomach, ovary,
“Tough Cases” Doug Wolf and Gil Y. Melmed Advances in IBD Hollywood, FL December, 2013.
Clinical and Molecular Genetic Spectrum of Slovenian Patients with CGD ESID Prague Spring Meeting 2007 Avčin T, Debeljak M, Markelj G, Anderluh G*, Glavnik.
Case Presentation 34 y/o male34 y/o male 5 years Crohn’s disease of ileum and Rt. colon5 years Crohn’s disease of ileum and Rt. colon 10 days – Fever,
General Principles of Medical and Surgical Management of Inflammatory Bowel Disease Jeraldine S. Orlina Colorectal Conference December 22, 2005.
IBD Patient Update Case Vignettes 12 November 2011.
Therapeutic management in a boy with XL-CGD complicated by invasive aspergillosis. Department of Immunology Children’s Memorial Health Institute Warsaw.
NYU Medical Grand Rounds Clinical Vignette Andy Levy, MD PGY-2 March 26, 2013 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
PANEL DISCUSSION SURGERY FOR CROHNS DISEASE. AD 24 female Crohns disease since 2001 on penatasa, budesonide, prednisolone needle phobia resolved by psychologist.
CLINICAL AND ENDOSCOPIC CORRELATION OF INFLAMMATORY BOWEL DISEASE Coordinator: Prof. Univ. Dr. Simona Băţagă Students: Andra Oltean Stoica Ioan Adrian.
Which of the following is/are true regarding Ulcerative Colitis (UC)? A. Females are affected more then males. B. Surgery is curative. C. The most consistent.
Inflammatory Bowel Disease (IBD)
Crohn Disease (Regional Enteritis)
Clinical Vignette: Medical Grand Rounds Joshua L. Denson MD Internal Medicine PGY2 January 7, 2013 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
It's Time A 63-year-old woman was admitted because of severe abdominal pain, fatigue and bloody diarrhea.
IBD Cases Stephen B. Hanauer, MD Professor of Medicine Feinberg School of Medicine Medical Director, Digestive Health Center.
Successful sequential cord blood stem cell transplant and intestinal-colon transplant for combined immunodeficiency and intestinal failure.
A Novel Presentation of 6-Mercaptopurine Toxicity in a Patient with IBD Zachary C. Junga, MD, Nisha A. Shah, MD, and John D. Betteridge,
You Can Never Stop a Biologic
Natalizumab- Unmet Need in the Management of Crohn’s Disease Doug Wolf, M.D. Atlanta Gastroenterology Associates July 31, 2007.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Inflammatory Bowel Disease Crohn’s Disease And Ulcerative Colitis.
Kim Eastman RN,MSN, CNS. INFLAMMATORY BOWEL DISEASE  OVERVIEW  IMMUNOLOGIC DISEASE THAT RESULTS IN INTESTINAL INFLAMMATION  ULCERATIVE COLITIS  CROHN’S.
R2 정상완. Introduction  Perianal fistulas : ¼ of Crohn’s disease (CD)  physical and psychologic morbidity with a long-term risk of proctectomy  metronidazole,
MIGUEL REGUEIRO, WOLFGANG SCHRAUT, LEONARD BAIDOO, KEVIN E. KIP, ANTONIA R. SEPULVEDA, MARILYN PESCI, JANET HARRISON, SCOTT E. PLEVY GASTROENTEROLOGY 2009;136:441–450.
Improving outcome of Inflammatory Bowel Disease in children Dinesh Pashankar, MD Pediatric Gastroenterologist Director- Pediatric IBD program Yale University.
Chronic Granulomatous Disease
Dr Gill Watermeyer IBD Clinic Division of Gastroenterology
Inflammatory Bowel Disease (IBD)
LABORATORY PARAMATERS Day 1 (date of presentation)
18th Meeting of the European Association for Hematopathology
ULCERATIVE COLITIS Dr.Mohammadzadeh.
CASE DISCUSSION: Crohn's disease patient with bad perianal disease- are new therapies any help? Alana Wichmann, APN, MSN, FNP, Advanced Practice Nurse,
Crohn´s disease Domina Petric, MD.
Basics of PSC Christopher L. Bowlus, MD
Oral Vancomycin as a Therapeutic Option for PSC
Management of Clostridium Difficile Infection
Article by: Zubin Grover , Richard Muir, and Peter lewindon
Lecture 12 Gastrointestinal Disorders Inflammatory Bowel Disease
Inflammatory bowel disease and Ulcerative colitis
perforation of an ileal ulcer a patient with Behçet’s disease
Presentation transcript:

Patient 1 – acute abdomen 19 year old male – no prior medical history Just back from a trip to Israel Two days of “writhing in pain”, fever to – Similar episode about a week ago in Israel resolved Pediatrician – acute abdomen, wbc 30,000 CT – pelvic abscess, inflamed small and large bowel, inflamed Ileum

Questions In an acute presentation, how does one differentiate between: – Perforated appendix – Newly presenting Crohn’s with perforation – Other causes of pelvic abscess How do you determine which patients warrant emergency surgery, vs. which should be “cooled off” medically? What is your protocol for medical management prior to surgery?

Management 1.Abscess drained by IR 2.One week in ICU 3.IV antibiotics (Piperacillin/ Tazobactam) 3.NG suction to decompress 4.IV hydration 5.Pain medication 6.Parenteral nutrition 7.Re-imaging after 10 days

Questions What additional evaluation would you perform at this time to establish a Crohn’s diagnosis? Would you consider treating this patient medically? – Short term vs. long term? – With what agent? If you choose surgery, what is the appropriate time to intervene? – Laparoscopic vs. open?

“ Abdominal phlegmons in Crohn's disease: outcomes following antitumor necrosis factor therapy ” Thirteen patients with abdominal phlegmon treated with antibiotics and anti-TNF – 12 patients also had abscess Anti-TNF with antibiotics – Two patients underwent surgery within a year “Penetrating CD complicated by phlegmon formation may be safely and effectively managed with a combination of antibiotics and anti-TNF therapy” Selection bias? Cullen et al, IBD Journal 2013

Management and outcome Hospitalized with PN, NPO, decompression and medical management for approximately 3 weeks. EGD/Colonoscopy – no gastric or colonic disease Laparoscopic ileocecectomy – Fibrotic ileum and cecum – Residual abdominal abscesses – 30 cm of ileum plus cecum resected Uneventful recovery

Postoperative management How would you monitor patient postoperatively? – Clinical follow-up and labs only? – Small bowel imaging? – Colonoscopy (timing) What (if any) postoperative medical therapy would you utilize ? – Aminosalicylate – Thiopurine – Infliximab

Postoperative management and outcome Discussion with family and patient Opted for mercaptopurine – Transaminitis developed – Changed to low dose 6MP and allopurinol Surveillance 1 year after initial presentation – Normal MRI, normal colonoscopy No clinical or laboratory recurrence 3 years after his initial surgery. – Follow up colonoscopy planned

Presenting history 7 year old female Presented with Serratia osteomyelitis at 3 months of age History of multiple GI issues in infancy – Poor weight gain requiring NG tube – Diarrhea – Rectal bleeding as infant while breast-fed, responsive to mother eliminating milk from diet. Diagnosis of CGD by dihydrorhodamine test

Chronic granulomatous disease Winkelstein et al 2000; Medicine 79:155 Primary immunodeficiency characterized by inability of cells to kill bacteria and fungi. – Staphylococcus, Aspergillus cause serious infection – Catalase positive organisms – Pneumonia most common infection (80%) 75% of patients present under age 5 years Autosomal recessive or X-linked GI manifestations – Colitis present in approximately 20% – Perianal abscess – Gastric outlet obstruction Diagnosis – defective NADPH oxidase – Dihydrorhodamine test

Dihydrorhodamine test Children’s Hospital of Wisconsin Neutrophils given DHR dye, activated Normal neutrophils produce superoxides that oxidize DHR, resulting in fluorescence.

Chronic granulomatous disease Mimics Crohn disease on endoscopy and histology Granulomas in only 34 % (Levine, Histopathology 2005) Paucity of neutrophils compared to UC (Shappi JPGN 2003) Decreased CD68+ macrophages (Liu et al, IBD Journal 2009) Therapy – gamma-IFN, steroids, thalidomide, SCT

Clinical course Continued with diarrhea, anemia for over a year despite therapy. – Labial abscess grew E. coli By age 4: – 3 BM daily, no bleeding – Height at 25% ile, but falling off – Colonoscopy with ileal and colonic granulomas – Therapies included Alpha - Interferon Bactrim and fungal prophylaxis

Medical options for this colitis Aminosalicylates Antibiotics Probiotics Corticosteroids Azathioprine GM-CSF Anti-TNF agents

Medical options for this colitis Aminosalicylates - intolerant, got diarrhea Antibiotics – vancomycin for C. difficile Probiotics – VSL 3 Corticosteroids – recurrent courses Azathioprine – tried for over 6 months – unable to wean off steroids without worsening GM-CSF Anti-TNF agents?

Caution with anti-TNF in CGD! NIH published experience with 5 patients – All with active colitis despite thiopurines – Two deaths from opportunistic lung disease Infliximab effective for GI disease (including fistulizing disease), but severe infectious complications developed – B. cepacia – CMV colitis – S. aureus liver abscess

Potential options GM-CSF – Wang et al, J. Allergy Clinical Immunology 2005 Anakinra – Rationale – upregulation of IL-1 beta pathway – van de Veerdonk et al, Netherland Journal of Medicine 2011 Stem cell transplant – Controversial in CGD – No matched siblings in this case.

Current outcome Anakinra 200 mg daily for 3 weeks – Azathioprine stopped Diarrhea improving with 2 stools daily Prednisone weaned to 6 mg daily CRP improved from – 2.2 mg/dL to 0.9 mg/dL Plan for 3-6 months of Anakinra, the re- evaluate with colonoscopy

Fever in CD Patient on 6-MP

Presenting history 18 year old male with CD Maintained on 6-MP for four years with stable remission and mucosal healing Headache, fever and malaise Leukopenia and elevated transaminases No lymphadenopathy or HSM EBV IgM+ EBV PCR 291 copies/mcg DNA

Options Additional diagnostic tests? What to do with 6-MP? Follow-up?

Clinical course Initially improved Within a few weeks fevers & chills returned Became jaundiced

Options Additional diagnostic tests? Differential diagnosis?

Diagnostic Tests Hyponatremia, pancytopenia, elevated bilirubin and transaminases Increased EBV PCR Elevated sIL2R, ferritin Abdominal ultrasound: massive HSM Diagnosis? Other tests?

Diagnostic Tests EGD/colon: multiple gastric polypoid lesions with path consistent with EBV+ lymphoma Liver biopsy: EBV+ lymphoma infiltrate Bone marrow: hemophagocytosis PET-CT: widespread

Discussion What to do with 6MP with febrile illness/mono? RISK of EBV associated HLH or lymphoma with 6-MP? Different for primary EBV infection versus reactivation? Monitoring for this?